BLUE FJORD NORWAY Trademark

Trademark Overview


On Monday, September 27, 2021, a trademark application was filed for BLUE FJORD NORWAY with the United States Patent and Trademark Office. The USPTO has given the BLUE FJORD NORWAY trademark a serial number of 79326338. The federal status of this trademark filing is ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE as of Monday, January 30, 2023. This trademark is owned by Zobrius Pharma AS. The BLUE FJORD NORWAY trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceuticals, medical and veterinary preparations; dietetic food and substances adapted for medical or veterinary use; dietary supplements for human beings and animals; dietary supplements containing vitamins and minerals; edible fish oils for medical use; edible fish oils for medical purposes; edible marine oils for medical purposes; dietary supplements being fish oil capsules; dietary supplements being omega fatty acid capsules; pharmaceuticals and medical preparations for treating, preventing or ameliorating gastro-intestinal; pharmaceuticals and medical preparations for treating cardiovascular or inflammatory diseases and conditions, including irritable bowel syndrome, rheumatoid arthritis and psoriasis, or cognitive impairment; dietary supplements for treating, preventing or ameliorating gastro-intestinal diseases and conditions; dietary supplements for treating, preventing or ameliorating cardiovascular or inflammatory diseases and conditions, including irritable bowel syndrom...
blue fjord norway

General Information


Serial Number79326338
Word MarkBLUE FJORD NORWAY
Filing DateMonday, September 27, 2021
Status602 - ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE
Status DateMonday, January 30, 2023
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements


Goods and ServicesPharmaceuticals, medical and veterinary preparations; dietetic food and substances adapted for medical or veterinary use; dietary supplements for human beings and animals; dietary supplements containing vitamins and minerals; edible fish oils for medical use; edible fish oils for medical purposes; edible marine oils for medical purposes; dietary supplements being fish oil capsules; dietary supplements being omega fatty acid capsules; pharmaceuticals and medical preparations for treating, preventing or ameliorating gastro-intestinal; pharmaceuticals and medical preparations for treating cardiovascular or inflammatory diseases and conditions, including irritable bowel syndrome, rheumatoid arthritis and psoriasis, or cognitive impairment; dietary supplements for treating, preventing or ameliorating gastro-intestinal diseases and conditions; dietary supplements for treating, preventing or ameliorating cardiovascular or inflammatory diseases and conditions, including irritable bowel syndrome, rheumatoid arthritis and psoriasis, or cognitive impairment; edible fish oils and omega fatty acid capsules for treating, preventing or ameliorating gastro-intestinal diseases and conditions; edible fish oils and omega fatty acid capsules for treating, preventing or ameliorating cardiovascular or inflammatory diseases and conditions, including irritable bowel syndrome, rheumatoid arthritis and psoriasis, or cognitive impairment

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateFriday, November 26, 2021
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameZobrius Pharma AS
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressNO

Trademark Events


Event DateEvent Description
Sunday, February 18, 2024FINAL DECISION TRANSACTION PROCESSED BY IB
Tuesday, January 30, 2024FINAL DISPOSITION NOTICE SENT TO IB
Tuesday, January 30, 2024FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Tuesday, May 16, 2023NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
Wednesday, April 26, 2023NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Wednesday, April 26, 2023NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
Monday, January 30, 2023ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND
Monday, January 30, 2023ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND
Monday, January 30, 2023ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
Sunday, September 18, 2022NEW REPRESENTATIVE AT IB RECEIVED
Tuesday, August 9, 2022REFUSAL PROCESSED BY IB
Saturday, July 16, 2022NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Saturday, July 16, 2022REFUSAL PROCESSED BY MPU
Thursday, June 30, 2022NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Wednesday, June 29, 2022NON-FINAL ACTION WRITTEN
Tuesday, June 28, 2022ASSIGNED TO EXAMINER
Friday, January 21, 2022NEW REPRESENTATIVE AT IB RECEIVED
Tuesday, November 30, 2021APPLICATION FILING RECEIPT MAILED
Friday, November 26, 2021NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, November 25, 2021SN ASSIGNED FOR SECT 66A APPL FROM IB